JELI: Joint Embedding-classifier Learning for improved Interpretability
We mentioned in a previous blog post the issues in machine learning for drug repurposing related to imbalanced drug-disease outcomes -that is, sparse results...
Five insights from our large-scale benchmark
By now, you should be aware that our objectives are to overcome the high cost, duration, and risk issues in traditional de novo drug development pipelines. T...
A large-scale benchmark for collaborative filtering applied to drug repurposing
2025 starts with another of our papers [1] being currently in press at Scientific Reports!